Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

about

Pharmacotherapies for obesity: past, current, and future therapies Serotonergic drugs and valvular heart disease Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity Off-label drugs for weight management.

P2860

Q21296814-3E37C6A4-26C0-43D7-88D9-2DCF5CCEFF73 Q24646869-18741890-9981-4FD5-B36E-7A32A27B5308 Q33572190-C1A9BB7B-42E6-43BB-8C78-5040F00DF59D Q33806796-5A2A3F51-73C3-460A-8628-3F6AB04FD46A

P2860

Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

Item

http://www.wikidata.org/entity/Q36673903

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Comparison of combinations of ...... and echocardiographic status.

@ast

Comparison of combinations of ...... and echocardiographic status.

@en

type

Item

label

Comparison of combinations of ...... and echocardiographic status.

@ast

Comparison of combinations of ...... and echocardiographic status.

@en

prefLabel

Comparison of combinations of ...... and echocardiographic status.

@ast

Comparison of combinations of ...... and echocardiographic status.

@en

P1476

Comparison of combinations of ...... t and echocardiographic status

@en

P2093

Atkinson RL

http://www.w3.org/2001/XMLSchema#string

Dhurandhar NV

http://www.w3.org/2001/XMLSchema#string

Rahko PS

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

Valvular heart disease associated with fenfluramine-phentermine

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy

Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters

Pharmaceutical cost savings of treating obesity with weight loss medications

Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine

Effects of Nefazodone on Body Weight

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

P2888

sj.ijo.0803498

P304

850-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.IJO.0803498

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leah D. Whigham

P577

2006-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6653537

http://www.w3.org/2001/XMLSchema#string

P698

17146452

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

about

P2860

P2860

Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921